RETINAPHARMA ANNOUNCES FDA CLEARANCE OF DEVICE TO MORE EFFECTIVELY DIAGNOSE GLAUCOMA

RetinaPharma Technologies has announced FDA clearance to market its proprietary TonoPach that enables more accurate diagnosis of glaucoma and ocular hypertension, leading causes of preventable blindness among adults. TonoPach is the first device to enable simultaneous determination of intraocular pressure and corneal thickness, increasing the accuracy and predictive power of the IOP measurement that is traditionally used alone.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/01-06-2005/0002772879&EDATE=)